Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity.

Kuhajda FP, Aja S, Tu Y, Han WF, Medghalchi SM, El Meskini R, Landree LE, Peterson JM, Daniels K, Wong K, Wydysh EA, Townsend CA, Ronnett GV.

Am J Physiol Regul Integr Comp Physiol. 2011 Jul;301(1):R116-30. doi: 10.1152/ajpregu.00147.2011. Epub 2011 Apr 13.

2.

The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice.

Yazdi M, Ahnmark A, William-Olsson L, Snaith M, Turner N, Osla F, Wedin M, Asztély AK, Elmgren A, Bohlooly-Y M, Schreyer S, Lindén D.

Biochem Biophys Res Commun. 2008 May 16;369(4):1065-70. doi: 10.1016/j.bbrc.2008.02.156. Epub 2008 Mar 11.

PMID:
18339309
3.

Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons.

Briggs DI, Enriori PJ, Lemus MB, Cowley MA, Andrews ZB.

Endocrinology. 2010 Oct;151(10):4745-55. doi: 10.1210/en.2010-0556. Epub 2010 Sep 8.

PMID:
20826561
5.

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.

Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK, Véniant MM.

Diabetes. 2009 Jan;58(1):250-9. doi: 10.2337/db08-0392. Epub 2008 Oct 7.

6.

Consumption of a high-fat diet induces central insulin resistance independent of adiposity.

Clegg DJ, Gotoh K, Kemp C, Wortman MD, Benoit SC, Brown LM, D'Alessio D, Tso P, Seeley RJ, Woods SC.

Physiol Behav. 2011 Apr 18;103(1):10-6. doi: 10.1016/j.physbeh.2011.01.010. Epub 2011 Jan 15.

7.

Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.

Liu LF, Purushotham A, Wendel AA, Belury MA.

Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1671-82. Epub 2007 Feb 22.

PMID:
17322064
8.

Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.

Patel HR, Qi Y, Hawkins EJ, Hileman SM, Elmquist JK, Imai Y, Ahima RS.

Diabetes. 2006 Nov;55(11):3091-8.

9.

Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.

Stofkova A, Skurlova M, Kiss A, Zelezna B, Zorad S, Jurcovicova J.

Endocr Regul. 2009 Jul;43(3):99-106.

PMID:
19817504
10.

Obese reversal by a chronic energy restricted diet leaves an increased Arc NPY/AgRP, but no alteration in POMC/CART, mRNA expression in diet-induced obese mice.

Yu Y, Deng C, Huang XF.

Behav Brain Res. 2009 Dec 14;205(1):50-6. doi: 10.1016/j.bbr.2009.07.003. Epub 2009 Jul 16.

PMID:
19616032
11.

Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.

Kowalski TJ, Spar BD, Weig B, Farley C, Cook J, Ghibaudi L, Fried S, O'Neill K, Del Vecchio RA, McBriar M, Guzik H, Clader J, Hawes BE, Hwa J.

Eur J Pharmacol. 2006 Mar 27;535(1-3):182-91. Epub 2006 Mar 13.

PMID:
16540104
12.

Respective contributions of maternal insulin resistance and diet to metabolic and hypothalamic phenotypes of progeny.

Carmody JS, Wan P, Accili D, Zeltser LM, Leibel RL.

Obesity (Silver Spring). 2011 Mar;19(3):492-9. doi: 10.1038/oby.2010.245. Epub 2010 Oct 14.

13.

Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice.

Jiang C, Qu A, Matsubara T, Chanturiya T, Jou W, Gavrilova O, Shah YM, Gonzalez FJ.

Diabetes. 2011 Oct;60(10):2484-95. doi: 10.2337/db11-0174. Epub 2011 Aug 26.

14.

Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.

Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.

Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.

PMID:
18794597
15.

Mice deleted for GPAT3 have reduced GPAT activity in white adipose tissue and altered energy and cholesterol homeostasis in diet-induced obesity.

Cao J, Perez S, Goodwin B, Lin Q, Peng H, Qadri A, Zhou Y, Clark RW, Perreault M, Tobin JF, Gimeno RE.

Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1176-87. doi: 10.1152/ajpendo.00666.2013. Epub 2014 Apr 8.

PMID:
24714397
16.

C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.

Tamura Y, Sugimoto M, Murayama T, Minami M, Nishikaze Y, Ariyasu H, Akamizu T, Kita T, Yokode M, Arai H.

J Atheroscler Thromb. 2010 Mar 31;17(3):219-28. Epub 2010 Feb 24.

17.

C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.

Thupari JN, Landree LE, Ronnett GV, Kuhajda FP.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9498-502. Epub 2002 Jun 11.

18.

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.

Orellana-Gavaldà JM, Herrero L, Malandrino MI, Pañeda A, Sol Rodríguez-Peña M, Petry H, Asins G, Van Deventer S, Hegardt FG, Serra D.

Hepatology. 2011 Mar;53(3):821-32. doi: 10.1002/hep.24140. Epub 2011 Feb 11.

PMID:
21319201
19.

Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss.

Hoenig M, Thomaseth K, Waldron M, Ferguson DC.

Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R227-34. Epub 2006 Aug 10. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1291.

PMID:
16902186
20.

Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.

Coenen KR, Hasty AH.

Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E492-9. Epub 2007 Jun 12.

PMID:
17566116

Supplemental Content

Support Center